# The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study

> **NCT02390414** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 290 (actual)

## Conditions studied

- Myelodysplastic Syndromes (MDS)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02390414
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2023-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02390414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02390414, "The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02390414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*